We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+14.05%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$5.82B
AUM Growth
+$786M
Cap. Flow
+$219M
Cap. Flow %
3.76%
Top 10 Hldgs %
35.53%
Holding
313
New
38
Increased
59
Reduced
159
Closed
42

Top Buys

Rank Stock Value
1
APA icon
APA Corp
APA
+$107M
2
ALGN icon
Align Technology
ALGN
+$80.9M
3
LITE icon
Lumentum
LITE
+$68.1M
4
ATVI
Activision Blizzard
ATVI
+$48.8M
5
AMED
Amedisys
AMED
+$44.7M

Top Sells

Rank Stock Value
1
N
Netsuite Inc
N
+$71.5M
2
SBUX icon
Starbucks
SBUX
+$52.8M
3
CRAY
Cray, Inc.
CRAY
+$49.5M
4
SAVE
Spirit Airlines, Inc.
SAVE
+$42.6M
5
BIDU icon
Baidu
BIDU
+$40.3M

Sector Composition

Rank Sector Weight
1 Technology 22.25%
2 Consumer Discretionary 20.56%
3 Healthcare 18.35%
4 Communication Services 17.97%
5 Miscellaneous 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESPR
226
DELISTED
Esperion Therapeutics
ESPR
$52K ﹤0.01%
3,761
-69
-2% -$782
FNM
227
DELISTED
FANNIE MAE
FNM
$50K ﹤0.01%
29,651
-377
-1% -$636
ENPH icon
228
Enphase Energy
ENPH
$4.79B
$45K ﹤0.01%
37,756
-232
-0.6% -$409
TRVN
229
DELISTED
Trevena, Inc.
TRVN
$42K ﹤0.01%
10
PODD icon
230
Insulet
PODD
$9.63B
$40K ﹤0.01%
+982
New +$38.8K
B
231
Barrick Mining
B
$69.8B
$30K ﹤0.01%
1,666
TIME
232
DELISTED
Time Inc.
TIME
$30K ﹤0.01%
2,056
-145
-7% -$2.19K
BRK.B icon
233
Berkshire Hathaway Class B
BRK.B
$1.1T
$29K ﹤0.01%
200
GFN
234
DELISTED
General Finance Corporation
GFN
$27K ﹤0.01%
6,000
-20,025
-77% -$87.1K
TDOC icon
235
Teladoc Health
TDOC
$1.22B
$21K ﹤0.01%
1,142
-67,048
-98% -$1.18M
RNR icon
236
RenaissanceRe
RNR
$13.6B
$20K ﹤0.01%
167
NKE icon
237
Nike
NKE
$54.1B
$16K ﹤0.01%
298
-36,229
-99% -$2.05M
ALTO icon
238
Alto Ingredients
ALTO
$310M
$15K ﹤0.01%
2,218
XCOM
239
DELISTED
XTERA COMMUNICATIONS INC COM STK (DE)
XCOM
$14K ﹤0.01%
+25,004
New +$22.5K
ASPN icon
240
Aspen Aerogels
ASPN
$405M
-95,428
Closed -$474K
ATEX icon
241
Anterix
ATEX
$1.52B
-27,407
Closed -$586K
BLUE
242
DELISTED
bluebird bio
BLUE
-8,081
Closed -$4.53M
DBVT
243
DBV Technologies
DBVT
$746M
-299
Closed -$98K
EXP icon
244
Eagle Materials
EXP
$5.63B
-84,622
Closed -$6.53M
FIZZ icon
245
National Beverage
FIZZ
$2.93B
-3,176
Closed -$100K
HAIN icon
246
Hain Celestial
HAIN
$53.3M
-6,528
Closed -$325K
KMI icon
247
Kinder Morgan
KMI
$68.6B
-105,616
Closed -$1.98M
LPCN icon
248
Lipocine
LPCN
$17.8M
-23,812
Closed -$1.23M
OCUL icon
249
Ocular Therapeutix
OCUL
$2.27B
-45,150
Closed -$223K
SAGE
250
DELISTED
Sage Therapeutics
SAGE
-324,344
Closed -$9.77M

Similar funds

Gilder Gagnon Howe & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Gilder Gagnon Howe & Co held 313 positions worth $5.82B, up 16% from $5.03B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Gilder Gagnon Howe & Co deployed $219M of net new capital in Q3 2016, opening 38 new positions and adding to 59 existing holdings. Its largest new stake was APA Corp: 1,953,545 shares worth $125M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Starbucks, an estimated $52.8M trimmed.

  • Gilder Gagnon Howe & Co's largest Q3 2016 buy was APA Corp: 1,953,545 shares worth $125M.
  • Gilder Gagnon Howe & Co added most to Align Technology in Q3 2016, an estimated $80.9M increase.
  • Gilder Gagnon Howe & Co's biggest Q3 2016 reduction was Starbucks, cutting an estimated $52.8M.
  • Gilder Gagnon Howe & Co fully exited Netsuite Inc in Q3 2016, selling an estimated $71.5M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 36% of its $5.82B portfolio in Q3 2016.
  • Gilder Gagnon Howe & Co opened 38 new positions and closed 42 in Q3 2016.
  • Gilder Gagnon Howe & Co's portfolio value rose 16% quarter-over-quarter to $5.82B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2016, filed 1 Nov 2016.